This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Flagship Pioneering Innovations Vi, LLC. Active years: 2024.
Company Filing History:
Years Active: 2024
Title: Jenhan Tao: Innovator in Antigen Binding Molecules
Introduction
Jenhan Tao is a prominent inventor based in Cambridge, MA (US). She has made significant contributions to the field of biotechnology, particularly in the development of antigen binding molecules targeting SARS-CoV-2. Her work is crucial in the ongoing fight against viral infections, including COVID-19.
Latest Patents
Jenhan Tao holds 1 patent for her invention titled "Antigen binding molecules targeting SARS-CoV-2." This invention provides, in various embodiments, polypeptides that specifically bind to the Spike glycoprotein of severe acute respiratory syndrome coronavirus (SARS-CoV-2-Spike). The invention also includes fusion proteins comprising one or more of the polypeptides, polynucleotides encoding the polypeptides, vectors, and host cells suitable for expressing the polypeptides. Additionally, it outlines methods for treating viral infections, such as COVID-19.
Career Highlights
Jenhan Tao is associated with Flagship Pioneering Innovations Vi, LLC, where she continues to advance her research and innovations. Her work has positioned her as a key player in the biotechnology sector, focusing on solutions that address pressing health challenges.
Collaborations
Some of her notable coworkers include Ross Steven Federman and John Ingraham. Their collaborative efforts contribute to the innovative environment at Flagship Pioneering Innovations Vi, LLC.
Conclusion
Jenhan Tao's contributions to the field of biotechnology, particularly in developing treatments for viral infections, highlight her role as an influential inventor. Her work continues to pave the way for advancements in medical science and public health.